ClinicalTrials.gg
Not yet recruitingNCT07359313Updated Jan 22, 2026

Incidence of Colon Ischemia in Patients After Cardiopulmonary Resuscitation (CPR)

An interventional study of colonoscopy in Cardiac Arrest (CA), sponsored by University Hospital Freiburg. Not yet recruiting at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-22.

Sponsored by University Hospital Freiburg · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Bedside colonoscopy 24-36 hours after successful CPR

Read the detailed description

According to previous observations, many patients after CPR develop acute non-occlusive mesenteric ischemia. However, due to the lack of established screening strategies, the number of unreported cases may be high. Routine colonoscopy at 24-36 hours after CPR may be a safe, easy and cost-effective strategy for early detection of severe mesenteric ischemia and transfer to surgical treatment. However, this strategy has not been formally evaluated in larger prospective cohorts. In our center, we perform routine colonoscopy at 24 to 36 hours after cardiac arrest in all patients who receive extracorporeal CPR (ECPR), i.e., in all patients with prolonged cardiac arrest refractory to conventional CPR measures who therefore receive venoarterial extracorporeal membrane oxygenation (VA ECMO) for cardiocirculatory support. In these patients, colonoscopy screening was feasible and safe, and our data suggest clinical benefit.

02

Conditions studied

  • Cardiac Arrest (CA)

Keywords

  • cardiac arrest
  • cardiopulmonary resuscitation
  • CPR
  • extracorporeal cardiopulmonary resuscitation
  • ECPR
  • VA ECMO
  • colonoscopy
  • mesenteric ischemia
03

In context

Heart Arrest

926 studies on the registry are indexed under Heart Arrest; 226 are open to participants now.

This study's planned enrollment of 200 is above the median of 100 across 518 interventional studies indexed under Heart Arrest.

Browse Heart Arrest studies →

Lead sponsor

University Hospital Freiburg is the lead sponsor of 94 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • adult patients (≥ 18 years) admitted to the participating department AND
  • in-hospital or out-of-hospital cardiac arrest (IHCA, OHCA)

Exclusion criteria

Exclusion Criteria:

  • resuscitation period of ≤ 5 minutes
  • awake and contactable patients (GCS ≥ 13)
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Other
    early colonoscopy after successful CPR

    bedside colonoscopy 24-36 hours after successful CPR

    Procedure: colonoscopy

Interventions

  • Procedurecolonoscopy

    bedside colonoscopy without bowel cleansing early (24-36h) after successful CPR

06

What researchers measure

Primary outcomes

  1. Detection of colon ischemia

    Detection of colon ischemia within 30 days after return of spontaneous circulation

    Time frame: from baseline (0 hours) until day 30

Secondary outcomes

  1. in-hospital mortality

    in-hospital mortality

    Time frame: from baseline (0 hours) until hospital discharge

  2. abdominal surgery ((hemi-)colectomy)

    number of patients requiring/receiving abdominal surgery ((hemi-)colectomy)

    Time frame: from baseline (0 hours) until hospital discharge

  3. functional outcome

    Cerebral Performance Category (CPC)

    Time frame: day 30, day 60 and day 90

  4. Liver function

    Liver function parameters: Quick/INR, AST, ALT, AP, g-GT

    Time frame: within 0-72 hours after CPR

  5. renal function

    Renal function parameters: creatinine, BUN

    Time frame: within 0-72 hours after CPR

  6. Urine output

    Urine output (ml)

    Time frame: within 0-72 hours after CPR

  7. Renal replacement therapy

    Implementation of renal replacement therapy within 30 days after return of spontaneous circulation

    Time frame: from baseline (day 0) until day 30

  8. Serum lactate

    Serum lactate

    Time frame: within 0-72 hours after CPR

  9. SOFA score

    SOFA

    Time frame: at 0 hours, 24 hours, 48 hours, 72 hours after CPR

  10. SAPS II score

    SAPS II

    Time frame: at 0 hours, 24 hours, 48 hours, 72 hours after CPR

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07359313
Lead sponsor
University Hospital Freiburg
Responsible party
PD Dr. Alexander Supady (Senior Physician, University Hospital Freiburg) — Principal investigator
First posted
Jan 22, 2026
Start date
Jan 7, 2026 (estimated)
Primary completion
Jan 6, 2028 (estimated)
Completion
Feb 6, 2028 (estimated)
Last update
Jan 22, 2026

Study contacts

Alexander Supady, MD, MPH
Contact
alexander.supady@uniklinik-freiburg.de
+49-761-270-34010

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion